Renowned portfolio manager Paul Black advises that to achieve consistent wealth creation, investors should focus on growth companies with superior culture and a strong competitive edge over their peers. He emphasizes that successful growth investing requires a positive outlook on the future, as optimists are capable of reaching great heights.
UBS sells shares worth Rs 480 crore in Concord Biotech, IIFL Securities, 2 more stocks via block deals
UBS sold holdings in Concord Biotech, Five Star Business Finance, IIFL Securities, and Marksans Pharma through block deals, totaling Rs 480 crore. The largest sale